Was betrifft es? Warum ist das wichtig?

Based on the Swiss law (e.g. HRA) and the necessity for research transparency, requires that research results are published.

 

The statistician supports and is involved in the publication of study results. Responsibilities include to:

  • Write a statistical report. The report summarizes the statistical analyses used to analyse the study data, and provides a presentation of study results (e.g. tables, graphs, pictures)
  • Assist in the writing of scientific publications (e.g. poster presentations, publications in scientific journals)
  • Update and present study results on recognized platforms (e.g. KOFAM, ClinicalTrials.gov, WHO, EudraCT)

 

The statistician must ensure that publications are statistically sound, results are accurately interpreted, and that research findings are presented in a clear and objective manner

Was muss ich befolgen?

As a SP-INV:

  • Ensure the statistician provides you with a statistical report, and that the interpretation of results are scientifically correct and presented in a clear and convincing manner
  • Consult and involve a statistician when writing and reviewing your scientific publications. Prior to publication, a scientific paper is initially subjected to a peer review of experts. The publication can only be published after all reviewers have approved the document.
  • Ensure results are registered on study registered platforms

 

Based on the requirements for research transparency, you are responsible to publish a summary of your research. Research results must be made available in:

  • A study relevant registry(ies), such as:
    • A primary registry recognized by the WHO (ICTRP registry network)
    • The registry of the U.S: National Library of Medicine (clinicaltrials.gov)
  • The supplementary federal database, using a Swiss national language (KOFAM)

Wo kann ich Hilfe anfordern?

Your local Research Support Centre can assist you with experienced staff regarding this topic

  • Basel, Departement Klinische Forschung (DKF), dkf.unibas.ch

  • Lugano, Clinical Trials Unit (CTU-EOC), ctueoc.ch

  • Bern, Department of Clinical Research (DCR), dcr.unibe.ch

  • Geneva, Clinical Research Center (CRC), crc.hug.ch

  • Lausanne, Clinical Research Center (CRC), chuv.ch

  • St. Gallen, Clinical Trials Unit (CTU), h-och.ch

  • Zürich, Clinical Trials Center (CTC), usz.ch

External Links

Swissethics – see in particular

  • RAPS Registry, a database of all projects approved by the ethics committees in Switzerland

Declaration of Helsinki – see in particular principle

  • 36 Publication of research results

SAMS Research with human subjects – see in particular chapter

  • Chapter 11 Publication of study results

Swiss and international registries:

 

Swiss Law

HRA – see in particular article

  • Art. 56 Registration

ClinO – see in particular articles and annex

  • Art. 64 Approved registers and data to be entered
  • Annex 5
    • 1. Data to be entered in a register
    • 2. Data to be entered in the supplementary database
  • Art. 65 Time of registration
  • Art. 66 Responsibility
  • Art. 67 Portal: public access to clinical trials in Switzerland

ClinO-MD – See in particular articles

  • Art. 41 Registration
  • Art. 42 Publication of results
Abkürzungen
  • ClinO – Clinical Trials Ordinance
  • ClinO-MD – Ordinance on Clinical Trials of Medical Devices
  • CTU – Clinical Trials Unit
  • EudraCT – European Union Drug Regulating Authorities Clinical Trials Database
  • HRA - Human Research Act
  • KOFAM – Coordination Portal for Human Research
  • SAMS – Swiss Academy of Medical Sciences
  • SP-INV – Sponsor-Investigator
  • WHO – World Health Organization
Completion ↦ Statistic Methodology ↦ Publication ↦ Statistician Responsibility
Study
Basic

Provides some background knowledge and basic definitions

Basic Monitoring
Basic Drug or Device
Concept

Starts with a study idea

Ends after having assessed and evaluated study feasibility

Concept Statistic Methodology
Concept Drug or Device
Development

Starts with confidence that the study is feasible

Ends after having received ethics and regulatory approval

Development Drug or Device
Set-Up

Starts with ethics and regulatory approval

Ends after successful study initiation

Set-Up Ethics and Laws
Set-Up Statistic Methodology
Set-Up Quality and Risk
Set-Up Drug or Device
Conduct

Starts with participant recruitment

Ends after the last participant has completed the last study visit

Conduct Statistic Methodology
Conduct Drug or Device
Completion

Starts with last study visit completed

Ends after study publication and archiving

Completion Drug or Device
Current Path (click to copy): Completion ↦ Statistic Methodology ↦ Publication ↦ Statistician Responsibility

Please note: the Easy-GCS tool is currently under construction.